Mercy BioAnalytics
PrivateLast Round
Series B
Sep 3, 2025
Total Funding Raised
$127.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mercy BioAnalytics is a biotechnology company that develops a liquid biopsy assay platform for the early detection of cancer through the analysis of tumor-derived extracellular vesicles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mercy BioAnalytics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Mercy BioAnalytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 3, 2025 | ||||
| Series A | Apr 3, 2023 | ||||
| Series A | Jan 29, 2021 |
Key People
Founding team and executive leadership
Mercy BioAnalytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Horizons | Series A |
| Mindshift Capital | Series B |
| iSelect Fund | Series A, Series B |
| Perceptive Advisors | Series B |
| BrightEdge | Series A |
| Portfolia | Series B |
| Hatteras Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2026
Darrin Crisitello appointed as new Chief Commercial Officer.
- Dec 16, 2025
Now described as a commercial-stage biotechnology company.
Mercy BioAnalytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mercy BioAnalytics's valuation, stock price, and market status.